Form 4 for CAH Cardinal Health
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0000721371-22-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-05 | 2022-12-01 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | F - Tax | $80.17 | -380 | 26.9K | -1% | -$30.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-01 | F | D | 380 | $80.17 | 26,921 | D | — | — | (F2) Reflects closing price on prior business day. |